NetworkNewsBreaks

FridayOct 07, 2022 11:13 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Advancement of Berubicin Clinical Trial Featured in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio release covers CNS Pharmaceuticals’ recent announcement that highlights the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of glioblastoma multiforme (“GBM”), one of the…

Continue Reading

ThursdayOct 06, 2022 2:47 pm

NetworkNewsBreaks – Marathon Digital Holdings Inc. (NASDAQ: MARA) Reports September 2022 Bitcoin Production, Mining Operation Numbers

Marathon Digital Holdings (NASDAQ: MARA), a leader in supporting and securing the Bitcoin ecosystem, has released unaudited Bitcoin (“BTC”) production and miner installation updates for September 2022. According to the announcement, Marathon produced 360 BTC in September 2022, with a total of 616 BTC in Q3 2022. In addition, the company noted that total Bitcoin Holdings reached 10,670 BTC, which represents a fair market value of $207.3 million. Looking forward, the company observed that current operations at its King Mountain wind farm are in line with expectations. The announcement also noted that the King Mountain facility is hosted by Compute North,…

Continue Reading

ThursdayOct 06, 2022 2:32 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Elevating Performance with Expanded Team

Flora Growth Corp. (NASDAQ: FLGC), throughout 2022, has been implementing its hiring strategy that has seen the appointment of several key individuals whose proven talents and productivity are critical to the company’s goal of delivering the most compelling customer experiences. “Flora Growth ushered in the new year with the appointment of Tim Leslie as chairman of its newly formed advisory board. It would later bring Derek Pedro, an industry-leading cannabis genetics and cultivation expert, on board as an advisor and named Vessel founder James Choe as chief strategy officer. In February 2022, Flora Growth announced the appointment of Jessie Casner…

Continue Reading

ThursdayOct 06, 2022 2:17 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Redefining Drug Delivery Platforms

Lexaria Bioscience Corp. (NASDAQ: LEXX) has remained committed to improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream. “Moreover, as a global innovator in drug delivery platforms, the company has not shied away from advancing its research to cut across various health conditions, including but not limited to hypertension, epilepsy, diabetes, and dementia, among others. These efforts have yielded 27 granted patents around the world since 2014, with approximately 50 additional patents pending. It also has national filings in over 40 jurisdictions with the highest commercial potential, reflecting the company’s commitment to creating shareholder value and pushing its technology…

Continue Reading

ThursdayOct 06, 2022 2:00 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Lays Foundation for Significantly Expanded Manufacturing, Distribution Infrastructure

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, recently signed a management services agreement (“MSA”), marking a key milestone as the company actively strengthens its position in the California cannabis space. “SGMD signed the MSA through its subsidiary, SugarRush, which entered into the agreement with Canndis Inc., a California cannabis micro license holder. Canndis holds a license that covers delivery, manufacturing, distribution, and cultivation rights, and the agreement will enable Sugarmade to expand its manufacturing and distribution footprint,” a recent article reads. “Sugarmade is anticipating harvesting [its first crop], an accomplishment made possible through the company’s acquisition…

Continue Reading

ThursdayOct 06, 2022 1:17 pm

NetworkNewsBreaks – GSMI’s Future Workforce Conference to Feature Insight into Establishing Productive, Empowered Teams

Global Strategic Management Institute (“GSMI”), a cutting-edge conference production company focused on promoting disruptive innovation, will be hosting the Future Workforce Conference (“FWC”) in a virtual format on Oct. 11-13, 2022. The three-day industry flagship event caters to corporate professionals specializing in human resources, talent acquisition, workforce strategy and development, as well as digital transformation, which is arguably the most important emerging trend of the coming decade. The FWC will feature a unique lineup of experts and senior-level executives from across a variety of marquee companies that will guide attendees and break down the component processes in the workplace, to…

Continue Reading

ThursdayOct 06, 2022 1:12 pm

NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Participate at Upcoming Dawson James Small Cap Growth Conference

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is scheduled to participate in the 7th annual Dawson James Small Cap Growth Conference. Silo Pharma CEO Eric Weisblum will present at the event, which is scheduled for Oct. 12, 2022, in Jupiter, Florida. Weisblum’s presentation will include an overview of Silo Pharma’s acquisition and development of intellectual property and technology rights from leading universities and researchers, including the use of the psychedelic drugs. The presentation will also feature a summary of Silo’s the diversified pipeline, which is focused on underserved rare disease,…

Continue Reading

ThursdayOct 06, 2022 1:01 pm

NetworkNewsBreaks – Odyssey Health Inc. (ODYY) Issues Recap of Concussion Drug Development Program

Odyssey Health (OTC: ODYY), a company focused on developing unique, life-saving medical products, today provided a recap of its concussion drug development program. Concussions affect millions worldwide and represent an ‘unmet’ medical need, while repetitive concussions can increase the risk of developing chronic traumatic encephalopathy (“CTE”) and other neuropsychiatric disorders. Since acquisition of the intellectual property and all rights to the drug on March 1, 2021, Odyssey has made significant progress in its development program. Among many key milestones provided in the update, the company announced successful completion of the pre-clinical toxicology program and IND enabling safety studies for a…

Continue Reading

ThursdayOct 06, 2022 12:41 pm

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Platform to Add 24/7 Heart Monitoring Capability

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, today announced the expansion of its product portfolio pipeline to serve the growing cardiac device wearable technology market by bringing clinically relevant diagnostic information to patients and clinicians. According to the update, the product pipeline advancement allows for the addition of arrhythmia detection capabilities to address the multibillion global market for atrial fibrillation and other arrhythmia monitoring. “Adding smartwatch connectivity to our platform is a significant development as it extends our portfolio by enabling 24/7 heart monitoring…

Continue Reading

ThursdayOct 06, 2022 12:29 pm

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Announces New CFO Appointment

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) today announced its appointment  announce the appointment of Sean Hennessy as chief financial officer, effective immediately. Sean previously held the position of vice president, finance and controller. “We are excited to add Sean to our executive team,” said Chase Edgelow, CEO of EverGen. “Sean brings extensive financial and strategic experience to EverGen. He has been deeply involved with EverGen since the beginning of this year and this move is a seamless transition to bring our CFO role in-house. We would like to thank Natasha Monk, our interim CFO and partner at Affirm LLP, who will…

Continue Reading